Reaching a Genetic and Molecular Understanding of Skeletal Development
Tóm tắt
Từ khóa
Tài liệu tham khảo
Acampora, 1999, Craniofacial, vestibular and bone defects in mice lacking the Distal-less-related gene Dlx5, Development, 126, 3795, 10.1242/dev.126.17.3795
Arai, 1999, Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors, J. Exp. Med., 190, 1741, 10.1084/jem.190.12.1741
Arch, 1998, Tumor necrosis factor receptor-associated factors (TRAFs)—a family of adapter proteins that regulates life and death, Genes Dev., 12, 2821, 10.1101/gad.12.18.2821
Beedles, 1999, A putative role for c-Fos in the pathophysiology of Paget's disease, J. Bone Miner. Res., 14, 21, 10.1002/jbmr.5650140206
Bell, 1997, SOX9 directly regulates the type-II collagen gene, Nat. Genet., 16, 174, 10.1038/ng0697-174
Brunet, 1998, Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton, Science, 280, 1455, 10.1126/science.280.5368.1455
Bucay, 1998, Osteoprotegrin-deficient mice develop early onset osteoporosis and arterial calcification, Genes Dev., 12, 1260, 10.1101/gad.12.9.1260
Burgess, 1999, The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts, J. Cell Biol., 145, 527, 10.1083/jcb.145.3.527
Canalis, 1993, Insulin like growth factors and the local regulation of bone formation, Bone, 14, 273, 10.1016/8756-3282(93)90151-Y
Capdevila, 2001, Patterning mechanisms controlling vertebrate limb development, Annu. Rev. Cell Dev. Biol., 17, 87, 10.1146/annurev.cellbio.17.1.87
Caplan, 1987, The cellular and molecular embryology of bone formation
Chambers, 2000, Regulation of the differentiation and function of osteoclasts, J. Pathol., 192, 4, 10.1002/1096-9896(2000)9999:9999<::AID-PATH645>3.0.CO;2-Q
Chung, 2001, Indian hedgehog couples chondrogenesis to osteogenesis in endochondral bone development, J. Clin. Invest., 107, 295, 10.1172/JCI11706
Chusho, 2001, Dwarfism and early death in mice lacking C-type natriuretic peptide, Proc. Natl. Acad. Sci. USA, 98, 4016, 10.1073/pnas.071389098
Corral, 1998, Dissociation between bone resorption and bone formation in osteopenic transgenic mice, Proc. Natl. Acad. Sci. USA, 95, 13835, 10.1073/pnas.95.23.13835
Craig, 1987, The spatial and temporal pattern of collagens I and II and keratan sulphate in the developing chick metatarsophalangeal joint, Development, 99, 383, 10.1242/dev.99.3.383
Crowe, 1999, Delta-1 negatively regulates the transition from prehypertrophic to hypertrophic chondrocytes during cartilage formation, Development, 126, 987, 10.1242/dev.126.5.987
Dabovic, 2002, Bone abnormalities in latent TGF-beta binding protein (Ltbp)-3-null mice indicate a role for Ltbp-3 in modulating TGF-beta bioavailability, J. Cell Biol., 156, 1, 10.1083/jcb.200111080
Daluiski, 2001, Bone morphogenetic protein-3 is a negative regulator of bone density, Nat. Genet., 27, 84, 10.1038/83810
Darnay, 1999, Activation of NF-κB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-κB inducing kinase, Identification of a novel TRAF, 6, 7724
David, 2001, Carbonic anhydrase II is an AP-1 target gene in osteoclasts, J. Cell. Physiol., 188, 89, 10.1002/jcp.1099
Deng, 1996, Fibroblast growth factor receptor 3 is a negative regulator of bone growth, Cell, 84, 911, 10.1016/S0092-8674(00)81069-7
Dougall, 1999, RANK is essential for osteoclast and lymph node development, Genes Dev., 13, 2412, 10.1101/gad.13.18.2412
Ducy, 1999, A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development, Genes Dev., 13, 1025, 10.1101/gad.13.8.1025
Duong, 2001, Regulation of osteoclast formation and function, Rev. Endocr. Metab. Disord., 2, 95, 10.1023/A:1010063225902
Emery, 1998, Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL, J. Biol. Chem., 273, 14363, 10.1074/jbc.273.23.14363
Engsig, 2000, Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones, J. Cell Biol., 151, 879, 10.1083/jcb.151.4.879
Erlebacher, 1996, Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype, J. Cell Biol., 132, 195, 10.1083/jcb.132.1.195
Felix, 1990, Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse, Endocrinology, 127, 2592, 10.1210/endo-127-5-2592
Fleischmann, 2000, Fra-1 replaces c-Fos-dependent functions in mice, Genes Dev., 14, 2695, 10.1101/gad.187900
Foster, 1994, Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene, Nature, 372, 525, 10.1038/372525a0
Franzoso, 1997, Requirement for NF-kappaB in osteoclast and B-cell development, Genes Dev., 11, 3482, 10.1101/gad.11.24.3482
Gerber, 1999, VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation, Nat. Med., 5, 623, 10.1038/9467
Gong, 2001, LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development, Cell, 107, 513, 10.1016/S0092-8674(01)00571-2
Gruneberg, 1973, The anatomy and development of brachypodism in the mouse, J. Embryol. Exp. Morphol., 30, 119
Haigh, 2000, Conditional inactivation of VEGF-A in areas of collagen2a1 expression results in embryonic lethality in the heterozygous state, Development, 127, 1445, 10.1242/dev.127.7.1445
Hall, 1988, The embryonic development of bone, Am. Sci., 76, 174
Hartmann, 2001, Wnt-14 plays a pivotal role in inducing synovial joint formation in the developing appendicular skeleton, Cell, 104, 341, 10.1016/S0092-8674(01)00222-7
Heldin, 1997, TGF-beta signalling from cell membrane to nucleus through SMAD proteins, Nature, 390, 465, 10.1038/37284
Hodgkinson, 1993, Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic helix-loop-heliz zipper protein, Cell, 74, 395, 10.1016/0092-8674(93)90429-T
Horton, 1993, Cartilage morphology
Hsu, 1999, Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand, Proc. Natl. Acad. Sci. USA, 96, 3540, 10.1073/pnas.96.7.3540
Inada, 1999, Maturational disturbance of chondrocytes in Cbfa1-deficient mice, Dev. Dyn., 214, 279, 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W
Iotsova, 1997, Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2, Nat. Med., 3, 1285, 10.1038/nm1197-1285
Jaubert, 1999, Three new allelic mouse mutations that cause skeletal overgrowth involve the natriuretic peptide receptor C gene (Npr3), Proc. Natl. Acad. Sci. USA, 96, 10278, 10.1073/pnas.96.18.10278
Jheon, 2001, Characterization of a novel KRAB/C2H2 zinc finger transcription factor involved in bone development, J. Biol. Chem., 276, 18282, 10.1074/jbc.M010885200
Jochum, 2000, Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1, Nat. Med., 6, 985, 10.1038/79676
Kanzler, 1998, Hoxa-2 restricts the chondrogenic domain and inhibits bone formation during development of the branchial area, Development, 125, 2587, 10.1242/dev.125.14.2587
Karaplis, 1994, Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene, Genes Dev., 8, 277, 10.1101/gad.8.3.277
Karsenty, 1999, The genetic transformation of bone biology, Genes Dev., 13, 3037, 10.1101/gad.13.23.3037
Kartsogiannis, 1999, Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues, Bone, 25, 525, 10.1016/S8756-3282(99)00214-8
Kato, M., Patel, M.S., Levasseur, R., Lobov, I., Chang, B., Glass, D.A., II, Hartmann, C., Li, L., Huang, T.-H., Brayton, C.F., et al. (2001). Cbfa1/Runx2-independent decrease in osteoblast proliferation, osteopenia and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor.
Kawakami, 1999, Involvement of Wnt-5a in chondrogenic pattern formation in the chick limb bud, Dev. Growth Differ., 41, 29, 10.1046/j.1440-169x.1999.00402.x
Kim, 1999, Regulation of chondrocyte differentiation by Cbfa1, Mech. Dev., 80, 159, 10.1016/S0925-4773(98)00210-X
Kobayashi, 2001, Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis, EMBO J., 20, 1271, 10.1093/emboj/20.6.1271
Komori, 1997, Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts, Cell, 89, 755, 10.1016/S0092-8674(00)80258-5
Lacey, 1998, Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation, Cell, 93, 165, 10.1016/S0092-8674(00)81569-X
Lanske, 1996, PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth, Science, 273, 663, 10.1126/science.273.5275.663
Lee, 1997, Transforming growth factor-beta regulation of bone morphogenetic protein-1/procollagen C-Proteinase and related proteins in fibrogenic cells and keratinocytes, J. Biol. Chem., 272, 19056, 10.1074/jbc.272.30.19059
Lefebvre, 1998, A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene, EMBO J., 17, 5718, 10.1093/emboj/17.19.5718
Linsenmayer, 1991, Collagen types IX and X in the developing chick tibiotarsus, Development, 111, 191, 10.1242/dev.111.1.191
Little, 2002, A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait, Am. J. Hum. Genet., 70, 11, 10.1086/338450
Liu, 2001, Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures, J. Cell Biol., 155, 157, 10.1083/jcb.200105052
Liu, 2002, Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18, Genes Dev., in press
Lomaga, 1999, TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling, Genes Dev., 13, 1015, 10.1101/gad.13.8.1015
Long, 2001, The CREB family of activators is required for endochondral bone development, Development, 128, 541, 10.1242/dev.128.4.541
Luchin, 2000, The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal differentiation of osteoclasts, J. Bone Miner. Res., 15, 451, 10.1359/jbmr.2000.15.3.451
Lupu, 2001, Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth, Dev. Biol., 229, 141, 10.1006/dbio.2000.9975
Ma, 1996, The molecular basis of Boston-type craniosynostosis, Hum. Mol. Genet., 5, 1915, 10.1093/hmg/5.12.1915
Manolagas, 2000, Birth and death of bone cells, Endocr. Rev., 21, 115
Mao, 2001, Low-density lipoprotein receptor-related protein-5 binds to axin and regulates the canonical Wnt Signaling Pathway, Mol. Cell, 7, 801, 10.1016/S1097-2765(01)00224-6
Matsuo, 2000, Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation, Nat. Genet., 24, 184, 10.1038/72855
McKercher, 1996, Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities, EMBO J., 15, 5647, 10.1002/j.1460-2075.1996.tb00949.x
Merino, 1999, Expression and function of Gdf-5 during digit skeletogenesis in the embryonic chick leg bud, Dev. Biol., 206, 33, 10.1006/dbio.1998.9129
Mitrovic, 1977, Development of the metatarsophalangeal joint of the chick embryo, Am. J. Anat., 150, 333, 10.1002/aja.1001500207
Mizuno, 1998, Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin, Biochem. Biophys. Res. Commun., 247, 610, 10.1006/bbrc.1998.8697
Mundlos, 1997, Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia, Cell, 89, 773, 10.1016/S0092-8674(00)80260-3
Murakami, 2000, Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway, Proc. Natl. Acad. Sci. USA, 97, 1113, 10.1073/pnas.97.3.1113
Naito, 1999, Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice, Genes Cells, 4, 353, 10.1046/j.1365-2443.1999.00265.x
Nakashima, 2002, The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation, Cell, 108, 17, 10.1016/S0092-8674(01)00622-5
Naski, 1998, Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3, Development, 125, 4977, 10.1242/dev.125.24.4977
Naski, 1996, Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia, Nat. Genet., 13, 233, 10.1038/ng0696-233
Ng, 1997, SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse, Dev. Biol., 183, 108, 10.1006/dbio.1996.8487
Ohbayashi, 2002, Fgf18 is required for osteogenesis and chondrogenesis in mice, Genes Dev., in press
Otto, 1997, Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development, Cell, 89, 765, 10.1016/S0092-8674(00)80259-7
Owens, 1999, Fra-1 potentiates osteoclastic differentiation in osteoclast-macrophage precursor cell lines, J. Cell. Physiol., 179, 170, 10.1002/(SICI)1097-4652(199905)179:2<170::AID-JCP7>3.0.CO;2-K
Polinkovsky, 1997, Mutations in CDMP1 cause autosomal dominant brachydactyly type C, Nat. Genet., 17, 18, 10.1038/ng0997-18
Poole, 1991, The growth plate
Reddi, 1997, Bone morphogenetic proteins, Cytokine Growth Factor Rev., 8, 11, 10.1016/S1359-6101(96)00049-4
Reimold, 1996, Chondrodysplasia and neurological abnormalities in ATF-2-deficient mice, Nature, 379, 262, 10.1038/379262a0
Rosenzweig, 1991, Atrial natriuretic factor and related peptide hormones, Annu. Rev. Biochem., 60, 229, 10.1146/annurev.bi.60.070191.001305
Rousseau, 1994, Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia, Nature, 371, 252, 10.1038/371252a0
Rudnicki, 1992, Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development, Cell, 71, 383, 10.1016/0092-8674(92)90508-A
Sabatakos, 2000, Overexpression of delta FosB transcription factor(s) increases bone formation and inhibits adipogenesis, Nat. Med., 6, 985, 10.1038/79683
Sahni, 1999, FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway, Genes Dev., 13, 1361, 10.1101/gad.13.11.1361
Satokata, 2000, Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation, Nat. Genet., 24, 391, 10.1038/74231
Schipani, 1995, A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia, Science, 268, 98, 10.1126/science.7701349
Schipani, 1997, Targeted expression of constitutively active receptors for parathyroid hormone and parathyroid hormone-related peptide delays endochondral bone formation and rescues mice that lack parathyroid hormone-related peptide, Proc. Natl. Acad. Sci. USA, 94, 13689, 10.1073/pnas.94.25.13689
Schreiber, 2000, Placental vascularisation requires the AP-1 component fra1, Development, 127, 4937, 10.1242/dev.127.22.4937
Shiang, 1994, Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia, Cell, 78, 335, 10.1016/0092-8674(94)90302-6
Smits, 2001, The transcription factors L-Sox5 and Sox6 are essential for cartilage formation, Dev. Cell, 1, 277, 10.1016/S1534-5807(01)00003-X
St-Jacques, 1999, Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation, Genes Dev., 13, 2072, 10.1101/gad.13.16.2072
Storm, 1994, Limb alterations in brachypodism mice due to mutations in a new member of the TGF beta-superfamily, Nature, 368, 639, 10.1038/368639a0
Storm, 1999, GDF5 coordinates bone and joint formation during digit development, Dev. Biol., 209, 11, 10.1006/dbio.1999.9241
Su, 1997, Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism, Nature, 386, 288, 10.1038/386288a0
Suda, 1998, Skeletal overgrowth in transgenic mice that overexpress brain natriuretic peptide, Proc. Natl. Acad. Sci. USA, 95, 2337, 10.1073/pnas.95.5.2337
Suda, 1999, Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families, Endocr. Rev., 20, 345, 10.1210/edrv.20.3.0367
Takayanagi, 2000, T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma, Nature, 408, 600, 10.1038/35046102
Takeda, 2001, Continuous expression of Cbfa1 in non-hypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocytes differentiation and partially rescues Cbfa1-deficient mice, Genes Dev., 15, 467, 10.1101/gad.845101
Tavormina, 1995, Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3, Nat. Genet., 9, 321, 10.1038/ng0395-321
Thomas, 2000, Inhibition of chondrocyte differentiation in vitro by constitutive and inducible overexpression of the c-fos proto-oncogene, J. Cell Sci., 113, 439, 10.1242/jcs.113.3.439
Thomas, 1997, Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1, Nat. Genet., 17, 58, 10.1038/ng0997-58
Thomas, 1996, A human chondrodysplasia due to a mutation in a TGF-beta superfamily member, Nat. Genet., 12, 315, 10.1038/ng0396-315
Tondravi, 1997, Osteopetrosis in mice lacking hematopoietic transcription factor PU.1, Nature, 386, 81, 10.1038/386081a0
Tribioli, 1999, The murine Bapx1 homeobox gene plays a critical role in embryonic development of the axial skeleton and spleen, Development, 126, 5699, 10.1242/dev.126.24.5699
Udagawa, 2000, Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function, Endocrinology, 141, 3478, 10.1210/endo.141.9.7634
Ueta, 2001, Skeletal malformations caused by overexpression of Cbfa1 or its dominant negative form in chondrocytes, J. Cell Biol., 153, 87, 10.1083/jcb.153.1.87
Vortkamp, 1996, Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein, Science, 273, 613, 10.1126/science.273.5275.613
Vu, 1998, MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes, Cell, 93, 411, 10.1016/S0092-8674(00)81169-1
Wagner, 2001, Genetic control of skeletal development, Curr. Opin. Genet. Dev., 11, 527, 10.1016/S0959-437X(00)00228-8
Wagner, 1994, Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9, Cell, 79, 1111, 10.1016/0092-8674(94)90041-8
Wang, 1990, Recombinant human bone morphogenetic protein induces bone formation, Proc. Natl. Acad. Sci. USA, 87, 2220, 10.1073/pnas.87.6.2220
Wang, 2001, Differential regulation of endochondral bone growth and joint development by FGFR1 and FGFR3 tyrosine kinase domains, Development, 128, 3867, 10.1242/dev.128.19.3867
Wang, 1991, A novel target cell for c-fos-induced oncogenesis, EMBO J., 10, 2437, 10.1002/j.1460-2075.1991.tb07783.x
Wang, 1992, Bone and hematopoietic defects in mice lacking c-fos, Nature, 360, 741, 10.1038/360741a0
Watanabe, 1997, Chondrocytes as a specific target of ectopic Fos expression in early development, Proc. Natl. Acad. Sci. USA, 94, 3994, 10.1073/pnas.94.8.3994
Wehrli, 2000, Arrow encodes an LDL-receptor-related protein essential for Wingless signalling, Nature, 407, 527, 10.1038/35035110
Weilbaecher, 2001, Linkage of M-CSF signaling to Mitf, TFE3, and the osteoclast defect in Mitf(mi/mi) mice, Mol. Cell, 8, 749, 10.1016/S1097-2765(01)00360-4
Wilson, 2001, The status of Wnt signalling regulates neural and epidermal fates in the chick embryo, Nature, 411, 325, 10.1038/35077115
Wong, 1999, TRANCE is a TNF family member that regulates dendritic cell and osteoclast function, J. Leukoc. Biol., 65, 715, 10.1002/jlb.65.6.715
Wong, 1998, The TRAF family of signal transducers mediates NF-κB activation by the TRANCE receptor, J. Biol. Chem., 273, 28355, 10.1074/jbc.273.43.28355
Wong, 1997, TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells, J. Biol. Chem., 272, 25190, 10.1074/jbc.272.40.25190
Yang, 2001, TGF-beta/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage, J. Cell Biol., 153, 35, 10.1083/jcb.153.1.35
Yasuda, 1998, Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG), Endocrinology, 139, 442, 10.1210/endo.139.3.5837
Yoshida, 2000, Negative regulation of BMP/Smad signaling by Tob in osteoblasts, Cell, 103, 1085, 10.1016/S0092-8674(00)00211-7
Zelzer, 2001, Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2, Mech. Dev., 106, 97, 10.1016/S0925-4773(01)00428-2
Zhao, 2000, Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice, Endocrinology, 141, 2674, 10.1210/endo.141.7.7585